Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01383798 · ClinicalTrials.gov registry record · NA

How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?

A NA study, sponsored by Cornell University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT01383798: Completed NA study, sponsored by Cornell University.

NCT01383798 is a NA study that has completed, run by Cornell University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01383798, a NA study, has completed, sponsored by Cornell University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The specific aims of the current study were: 1) To determine the prevalence of IDNA in a sample of female rowers at the beginning of a training season; 2) To determine how IDNA affects endurance training and performance at the beginning of a training season; 3) To determine how iron supplementation affects iron status, training and performance in IDNA female collegiate rowers. The researchers hypothesized that IDNA affects endurance performance in female collegiate rowers both in and outside of the laboratory, and that iron supplementation of IDNA rowers will improve iron status, and consequently, training quality via increased energetic efficiency.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Ferrous sulfate

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2008-08
Est. Completion 2009-12
Phase NA
Cornell University

66 total trials

What the finished NCT01383798 record still lists

NCT01383798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01383798 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01383798 about?

NCT01383798 is a clinical study titled "How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?". The specific aims of the current study were: 1) To determine the prevalence of IDNA in a sample of female rowers at the beginning of a training season; 2) To determine how IDNA affects endurance training and performance at the beginning of a training season; 3) To determine how iron supplementation ...

What is the current status of trial NCT01383798?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-08. Estimated completion is 2009-12.

What interventions are being tested in trial NCT01383798?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ferrous sulfate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01383798?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01383798's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01383798, the US trial registry maintained by the National Library of Medicine. NCT01383798 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.